<DOC>
	<DOCNO>NCT00774423</DOCNO>
	<brief_summary>This multicentric , randomize , double-blind study versus placebo , two parallel group treat evaluate efficacy tolerance Riluzole child young adult ( 6 20 year age ) SMA . ( Type II Type III ) .</brief_summary>
	<brief_title>Study Evaluate Efficacy Riluzole Children Young Adults With Spinal Muscular Atrophy ( SMA )</brief_title>
	<detailed_description>ASIRI study allow evaluate efficacy tolerance Riluzole child young adult ( 6 20 year age ) SMA . This multicentric , randomize , double-blind study versus placebo , two parallel group treat follow 2 year . It precede 7 day pharmacokinetic phase , concern 14 patient , aim provide information kinetic profile Riluzole child . The drug could stabilize patient condition , especially interrupt paralysis progression ; desire effect . There open-label study long term safety riluzole therapy spinal muscular atrophy type II III , patient previously enrol ASIRI double-blind study .</detailed_description>
	<mesh_term>Muscular Atrophy , Spinal</mesh_term>
	<mesh_term>Muscular Atrophy</mesh_term>
	<mesh_term>Riluzole</mesh_term>
	<criteria>Patients afflict spinal muscular atrophy , type II III , genetic defect confirm . Age 6 20 year old . Score MFM least 12 Negative pregnancy test woman childbearing age Signing inform consent form , appropriate information provide ( patient 18 year old , parent require sign form ; otherwise , ( ) agreement necessary ) . Patients already treat Riluzole Concomitant treatment : GAPAPENTINE , DEXTROMETHORPHANE , amantadine , hepatotoxic medication stop , experimental product Hepatic insufficiency : SGPT and/or SGOT level higher equal twice normal high limit Renal insufficiency ( creatinine 115 micromoles/l ) Severe cardiac insufficiency Current pneumopathy ( clinical sign acute episode , confirm pulmonary Xray , require specific treatment ) Pregnancy nurse woman ; nonabstinence absence effective contraception nubile woman Any pathology circumstance likely interfere regular followup No affiliation social insurance system</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Spinal muscular atrophy ( SMA )</keyword>
	<keyword>Degeneration motor neuron</keyword>
	<keyword>Anterior horn spinal cord</keyword>
	<keyword>Riluzole</keyword>
</DOC>